Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas

FRIEDBERG, Jonathan W ; MAHADEVAN, Daruka ; FINGERT, Howard ; DANAEE, Hadi ; BERNSTEIN, Steven H ; CEBULA, Erin ; PERSKY, Daniel ; LOSSOS, Izidore ; AGARWAL, Amit B ; JUNGAH JUNG ; BURACK, Richard ; XIAOFEI ZHOU ; LEONARD, E. Jane

Journal of clinical oncology, 2014-01, Vol.32 (1), p.44-50 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível